Jones RJ - Search Results

1

Impact of in vivo administration of interleukin 3 on proliferation, differentiation, and chemosensitivity of acute myeloid leukemia.

Gore SD, Weng LJ, Jones RJ, Cowan K, Zilcha M, Piantadosi S, Burke PJ. Gore SD, et al. Among authors: jones rj. Clin Cancer Res. 1995 Mar;1(3):295-303. Clin Cancer Res. 1995. PMID: 9815985 Clinical Trial.

2

Impaired erythropoietin response to anemia after bone marrow transplantation.

Miller CB, Jones RJ, Zahurak ML, Piantadosi S, Burns WH, Santos GW, Spivak JL. Miller CB, et al. Among authors: jones rj. Blood. 1992 Nov 15;80(10):2677-82. Blood. 1992. PMID: 1421381 Free article.

3

Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia.

Yeager AM, Vogelsang GB, Jones RJ, Farmer ER, Altomonte V, Hess AD, Santos GW. Yeager AM, et al. Among authors: jones rj. Blood. 1992 Jun 1;79(11):3031-5. Blood. 1992. PMID: 1586747 Free article.

4

Hexamethylene bisacetamide in myelodysplastic syndrome: effect of five-day exposure to maximal therapeutic concentrations.

Rowinsky EK, Conley BA, Jones RJ, Spivak JL, Auerbach M, Donehower RC. Rowinsky EK, et al. Among authors: jones rj. Leukemia. 1992 Jun;6(6):526-34. Leukemia. 1992. PMID: 1602791

5

Correlation of occult clonogenic leukemia drug sensitivity with relapse after autologous bone marrow transplantation.

Miller CB, Zehnbauer BA, Piantadosi S, Rowley SD, Jones RJ. Miller CB, et al. Among authors: jones rj. Blood. 1991 Aug 15;78(4):1125-31. Blood. 1991. PMID: 1868244 Free article.

6

Phase I study of combination drug purging for autologous bone marrow transplantation.

Rowley SD, Miller CB, Piantadosi S, Davis JM, Santos GW, Jones RJ. Rowley SD, et al. Among authors: jones rj. J Clin Oncol. 1991 Dec;9(12):2210-8. doi: 10.1200/JCO.1991.9.12.2210. J Clin Oncol. 1991. PMID: 1960561 Clinical Trial.

7

Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation.

Jones RJ, Ambinder RF, Piantadosi S, Santos GW. Jones RJ, et al. Blood. 1991 Feb 1;77(3):649-53. Blood. 1991. PMID: 1991174 Free article.

8

Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow grafts.

Rowley SD, Piantadosi S, Marcellus DC, Jones RJ, Davidson NE, Davis JM, Kennedy J, Wiley JM, Wingard JR, Yeager AM, et al. Rowley SD, et al. Among authors: jones rj. Bone Marrow Transplant. 1991 Mar;7(3):183-91. Bone Marrow Transplant. 1991. PMID: 2059755

9

The action of bryostatin on normal human hematopoietic progenitors is mediated by accessory cell release of growth factors.

Sharkis SJ, Jones RJ, Bellis ML, Demetri GD, Griffin JD, Civin C, May WS. Sharkis SJ, et al. Among authors: jones rj. Blood. 1990 Aug 15;76(4):716-20. Blood. 1990. PMID: 2200537 Free article.

10

Effects of the differentiating agent hexamethylene bisacetamide on normal and myelodysplastic hematopoietic progenitors.

Rowinsky EK, Donehower RC, Spivak JL, Burke PJ, Griffin CA, Jones RJ. Rowinsky EK, et al. Among authors: jones rj. J Natl Cancer Inst. 1990 Dec 19;82(24):1926-31. doi: 10.1093/jnci/82.24.1926. J Natl Cancer Inst. 1990. PMID: 2250314

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

759 results

Search Page

Filters